Connect with us

Business

BioNTech shares surge as vaccine-maker's profits soar on booming outlook – CBC.ca

Published

 on


German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, swung to a huge profit in the second quarter on record sales, with far more forecast to come.

The Mainz-based company said it made a profit of almost 2.8 billion euros in the three months between April and June of 2021. That’s about $4.1 billion Cdn. In the same period last year, the company was losing hundreds of millions of dollars.

But that was before the U.S. Food and Drug Administration, Health Canada and other public health agencies approved the company’s vaccine for emergency use.

Along with its manufacturing partner, Pfizer, the company has since signed deals to sell 2.2 billion doses of its vaccine this year and another 1 billion in 2022.

“We and our partner Pfizer have crossed the one billion mark for COVID-19 vaccine doses shipped worldwide,” CEO Ugur Sahin said in a release. “We are proud to have reached this great milestone after only six months and to have made a difference for people with our proprietary mRNA technology.”

The company says it will use its profits from its COVID-19 vaccine to develop and produce vaccines against other viruses. Human trials on an mRNA-based influenza vaccine are slated to begin this fall, and the company is aiming to have a working prototype of a malaria vaccine by next year. According to the WHO, malaria infects more than 200 million people every year, and kills more than 400,000 people annually.

The mRNA technology that BioNTech uses in its COVID vaccine was originally developed as a way to fight cancerous tumours, before the company turned its attention to a then-unknown respiratory virus coming out of China in late 2019.

Over breakfast, Sahin and his wife Özlem Türeci decided to apply the technology they’d been researching for two decades to the new threat. Since then, the company says it expects to sell 15.9 billion euros worth of the vaccine this year.

Shares in the company have surged in recent weeks, as evidence mounts that the vaccine provides good protection against even the more transmissible variants.

The U.S.-listed version of the company’s shares were worth about $100 US when the WHO declared COVID-19 a pandemic in March of 2020. On Friday, they closed at $389. 

They gained another 10 per cent on Monday when the company’s financials came out, and when markets opened, the shares were changing hands at around $439 a share.

The funds the company is making from its COVID vaccine will be used to develop those vaccines and others.

The company says it currently has 15 potential vaccines in the works for different cancers. Six of those vaccines have advanced to the stage of being used in human clinical trials.

BioNTech expects results from at least four of them to be released by the end of the year.

“We were able to advance multiple oncology programs across various technology platforms which are now entering later stage testing, providing the potential for introducing a series of product candidates to the market in the coming years,” Sahin said.

Adblock test (Why?)



Source link

Continue Reading

Business

Vaccination wallet cards will no longer be accepted as transition period ends for B.C.'s COVID vaccine cards – CBC.ca

Published

 on


Starting Monday, British Columbians wanting to access restaurants and other recreational spaces will not be able to use their original proof of vaccination and will have to use the province’s vaccine card in digital or paper form.

Residents were able to use their original proof of vaccination, such as the wallet card given out at vaccination clinics, to access non-essential spaces until Sunday as part of a transition period to the province’s vaccine card program.

Currently, residents need to show proof of one dose of COVID-19 vaccine using the vaccine card. From Oct. 13, proof of two doses will be required to access non-essential spaces.

Some of the venues that require the vaccine card include:

  • Indoor ticketed sporting events.
  • Indoor concerts.
  • Indoor theatre/dance/symphony events.
  • Restaurants (indoor and patio dining).
  • Night clubs.
  • Casinos.
  • Movie theatres.
  • Fitness centres/gyms (excluding youth recreational sport).
  • Businesses offering indoor high-intensity group exercise activities.
  • Organized indoor events (e.g., weddings, parties, conferences, meetings, workshops) with 50 or more people.
  • Discretionary organized indoor group recreational classes and activities.
  • Student housing on college and university campuses.

Cards are available through the provincial Health Gateway website. Once you’ve loaded the site, you need to enter your:

The vaccine card is a one-page file with your name, confirmed vaccination status and a QR code that will be scanned upon entry. You can take a screenshot of the card on your phone or print a paper copy. 

Adults aged 19 and over will also need to show a government-issued piece of photo ID.

The province says the introduction of the vaccine card on Sept. 13 led to an uptick in vaccine bookings, and Premier John Horgan called it a step toward reopening with “confidence.”

Exemptions

There are some exemptions to using B.C.’s vaccine card as proof of vaccination.

People from other Canadian provinces or territories must show an officially recognized vaccine record from their province or territory along with valid government photo ID.

International visitors must show proof of vaccination they used to enter Canada along with their passport.

Members of the Canadian Armed Forces can use their National Defence Canada COVID-19 vaccine record or card with their National Defence ID card. 

Adblock test (Why?)



Source link

Continue Reading

Business

Evergrande EV Unit Ends Proposed Shanghai Star Board Listing – Bloomberg Markets and Finance

Published

 on


Adblock test (Why?)



Source link

Continue Reading

Business

Will China rescue the troubled property group Evergrande? | Inside Story – Al Jazeera English

Published

 on


Adblock test (Why?)



Source link

Continue Reading

Trending